Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “California”
- Long-Term Follow-up of Subjects Who Were Treated With ST-920Active Not Recruiting
Sponsor: Sangamo Therapeutics
Fabry Disease · Fabry Disease, Cardiac Variant
United States, Australia, Canada, Germany, United Kingdom
- Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without DiabetesRecruiting
Sponsor: Regeneron Pharmaceuticals
Overweight or Obesity
United States
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationRecruiting
Sponsor: Regeneron Pharmaceuticals
Atrial Fibrillation (AF)
United States, Argentina, Brazil, Canada
- A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative ColitisActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Ulcerative Colitis
United States, Argentina, Australia, Austria, Belgium +29 more
Sponsor: Jaeb Center for Health Research
Proliferative Diabetic Retinopathy (PDR)
United States
Sponsor: Cellution Biologics
Diabetic Foot Ulcer
United States
Sponsor: NYU Langone Health
Systemic Lupus Erythematosus
United States
Sponsor: Vanderbilt University Medical Center
Heart Transplant · Pediatric Heart Transplant · Rejection · Cardiac MRI
United States
Sponsor: University of California, San Francisco
Motility Function
United States
- Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent GlioblastomaActive Not Recruiting
Sponsor: Jonsson Comprehensive Cancer Center
Recurrent Glioblastoma
United States
Sponsor: Jonsson Comprehensive Cancer Center
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · Invasive Breast Carcinoma
United States
- Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION TrialActive Not Recruiting
Sponsor: Jonsson Comprehensive Cancer Center
Localized Prostate Adenocarcinoma · Stage I Prostate Cancer AJCC v8 · Stage II Prostate Cancer AJCC v8 · Stage III Prostate Cancer AJCC v8
United States
- Empowered Relief for CaregiversNot Yet Recruiting
Sponsor: Stanford University
Chronic Pain · Musculoskeletal Pain · Fibromyalgia · Neuropathic Pain
United States
Sponsor: City of Hope Medical Center
Classic Hodgkin Lymphoma
United States
- HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman SyndromeActive Not Recruiting
Sponsor: Ionis Pharmaceuticals, Inc.
Angelman Syndrome
United States, Australia, France, Israel, Italy +1 more
Sponsor: Pfizer
Advanced or Metastatic Breast Cancer
United States, Argentina, Australia, Brazil, Canada +9 more
Sponsor: GlaxoSmithKline
Infections, Meningococcal
United States, Puerto Rico
Sponsor: Hoffmann-La Roche
Active Ulcerative Colitis
United States, Belgium, Germany, Poland, United Kingdom
- Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard TreatmentActive Not Recruiting
Sponsor: Boehringer Ingelheim
Lung Cancer, Non-squamous, Non-small Cell
United States, Argentina, Australia, Austria, Belgium +21 more
- Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA VectorActive Not Recruiting
Sponsor: University of California, Los Angeles
Adenosine Deaminase Severe Combined Immune Deficiency
United States
- Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee OsteoarthritisNot Yet Recruiting
Sponsor: Syntr Health Technologies, Inc.
Knee Osteoarthritis
United States
- Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator PhenotypeActive Not Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Glioma · Recurrent Malignant Glioma
United States
- Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic LeukemiaActive Not Recruiting
Sponsor: Jonsson Comprehensive Cancer Center
CD19 Positive · CD20 Positive · Recurrent Chronic Lymphocytic Leukemia · Recurrent Diffuse Large B-Cell Lymphoma
United States
Sponsor: UCB Biopharma SRL
Generalized Myasthenia Gravis
United States, Belgium, Canada, Czechia, Denmark +12 more
- Ocular Rosacea Biome StudyCompleted
Sponsor: University of California, San Francisco
Ocular Rosacea · Antimicrobial Resistance
United States